Onradivir
Onradivir (INN) is an antiviral drug.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Onradivir (INN) is an antiviral drug. In China it is approved for the treatment of influenza A infections in adults, excluding those at high risk for influenza-related complications. It acts as an inhibitor of influenza virus polymerase basic protein 2 (PB2), a crucial subunit of the virus' RNA polymerase complex.
It is being developed by Guangdong Raynovent Biotech. It is derived from pimodivir and has high chemical similarity to it.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1366570455 under CC BY-SA 4.0; modifications have been made.